全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Fungal Malignant Otitis Externa with Facial Nerve Palsy: Tissue Biopsy Aids Diagnosis

DOI: 10.1155/2014/192318

Full-Text   Cite this paper   Add to My Lib

Abstract:

Fungal malignant otitis externa (FMOE) is a serious and potentially life-threatening condition that is challenging to manage. Diagnosis is often delayed due to the low sensitivity of aural swabs and many antifungal drugs have significant side effects. We present a case of FMOE, where formal tissue sampling revealed the diagnosis and the patient was successfully treated with voriconazole, in addition to an up to date review of the current literature. We would recommend tissue biopsy of the external auditory canal in all patients with suspected FMOE in addition to routine microbiology swabs. 1. Introduction Malignant otitis externa (MOE) remains a relatively uncommon condition but can lead to serious morbidity or mortality as diagnosis is often delayed leading to initially ineffective treatment [1]. The infection begins in the external auditory canal, typically presenting with severe otalgia and purulent otorrhoea; it can rapidly spread via the ear canal soft tissue to the temporal bone resulting in osteomyelitis and subsequent cranial nerve palsies and intracranial infection. The prevalence of bacterial MOE is not accurately documented [2] and it is unknown whether fungal MOE is a repercussion of unsuccessfully treated bacterial otitis externa or if it represents a de novo presentation of fungal disease. The most commonly reported pathogen in malignant otitis externa is Pseudomonas aeruginosa [2]. Aspergillus species and Candida albicans have been implicated in fungal MOE. There are 32 previously reported cases of fungal MOE, usually occurring in patients with some form of immunosuppression—typically diabetes, acquired immunodeficiency, or malignancy. We present a case of fungal malignant otitis externa complicated by a facial nerve palsy that proved very difficult to achieve a formal diagnosis. 2. Case An 83-year-old man with type 2 diabetes presented with right sided otalgia and otorrhoea; examination revealed granulation tissue inferiorly in his ear canal at the Osseochondral junction. A clinical diagnosis of malignant otitis externa was made. Pseudomonas aeruginosa was grown on microbiological culture of the discharge, sensitive to ciprofloxacin. His condition was successfully treated over a period of three months with oral and topical ciprofloxacin and he was discharged from clinic pain-free with an otoscopically normal canal. One year later, he presented with left-sided grade III facial nerve palsy and a painful left ear (note this is the contralateral side to the original presentation). The left ear was initially otoscopically normal. CT and MR

References

[1]  M. J. Carfrae and B. W. Kesser, “Malignant otitis externa,” Otolaryngologic Clinics of North America, vol. 41, no. 3, pp. 537–549, 2008.
[2]  J. R. Grandis, B. F. Branstetter IV, and V. L. Yu, “The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations,” Lancet Infectious Diseases, vol. 4, no. 1, pp. 34–39, 2004.
[3]  A. E. Tarazi, J. A. Al-Tawfiq, and R. F. Abdi, “Fungal malignant otitis externa: pitfalls, diagnosis, and treatment,” Otology & Neurotology, vol. 33, pp. 769–773, 2012.
[4]  C. Halsey, H. Lumley, and J. Luckit, “Necrotising external otitis caused by Aspergillus wentii: a case report,” Mycoses, vol. 54, no. 4, pp. e211–e213, 2011.
[5]  P. Parize, M.-O. Chandesris, F. Lanternier et al., “Antifungal therapy of aspergillus invasive otitis externa: efficacy of voriconazole and review,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1048–1053, 2009.
[6]  S. S. Ling and C. Sader, “Fungal malignant otitis externa treated with hyperbaric oxygen,” International Journal of Infectious Diseases, vol. 12, no. 5, pp. 550–552, 2008.
[7]  W. Narozny, J. Kuczkowski, C. Stankiewicz, J. Kot, B. Mikaszewski, and T. Przewozny, “Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment,” European Archives of Oto-Rhino-Laryngology, vol. 263, no. 7, pp. 680–684, 2006.
[8]  A. Tzuku, P. Antonini, S. Ermanni, M. Dolina, E. Passega, and E. Bernasconi, “Necrotizing (Malignant) otitis externa: an unusual localization of mucormycosis,” Indian Journal of Medical Microbiology, vol. 24, no. 4, pp. 289–291, 2006.
[9]  C. Bellini, P. Antonini, S. Ermanni, M. Dolina, E. Passega, and E. Bernasconi, “Malignant otitis externa due to Aspergillus niger,” Scandinavian Journal of Infectious Diseases, vol. 35, no. 4, pp. 284–288, 2003.
[10]  J. C. Shelton, P. J. Antonelli, and R. Hackett, “Skull base fungal osteomyelitis in an immunocompetent host,” Otolaryngology, vol. 126, no. 1, pp. 76–78, 2002.
[11]  G. Finer, D. Greenberg, E. Leibovitz, A. Leiberman, I. Shelef, and J. Kapelushnik, “Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient,” Scandinavian Journal of Infectious Diseases, vol. 34, no. 3, pp. 227–229, 2002.
[12]  F. C. Chai, K. Auret, K. Christiansen, P. W. Yuen, and D. Gardam, “Malignant otitis externa caused by malassezia sympodialis,” Head & Neck, vol. 22, pp. 87–89, 2000.
[13]  D. Chen, A. K. Lalwani, J. W. House, and D. Choo, “Aspergillus mastoiditis in acquired immunodeficiency syndrome,” American Journal of Otology, vol. 20, no. 5, pp. 561–567, 1999.
[14]  C. L. Slack, D. W. Watson, M. J. Abzug, C. Shaw, and K. H. Chan, “Fungal mastoiditis in immunocompromised children,” Archives of Otolaryngology, vol. 125, no. 1, pp. 73–75, 1999.
[15]  A. Mu?oz and E. Martínez-Chamorro, “Radiology in focus. Necrotizing external otitis caused by Aspergillus fumigatus: computed tomography and high resolution magnetic resonance imaging in an AIDS patient,” Journal of Laryngology and Otology, vol. 112, no. 1, pp. 98–102, 1998.
[16]  B. D. Ress, M. Luntz, F. E. Telischi, T. J. Balkany, and M. L. H. Whiteman, “Necrotizing external otitis in patients with AIDS,” Laryngoscope, vol. 107, no. 4, pp. 456–460, 1997.
[17]  S. E. Kountakis, J. V. Kemper Jr., C. Y. J. Chang, D. J. M. DiMaio, and C. M. Stiernberg, “Osteomyelitis of the base of the skull secondary to Aspergillus,” American Journal of Otolaryngology, vol. 18, no. 1, pp. 19–22, 1997.
[18]  P. D. Yates, “Aspergillus mastoiditis in a patient with acquired immunodeficiency syndrome,” Journal of Laryngology and Otology, vol. 111, no. 6, pp. 560–561, 1997.
[19]  W. B. Harley, J. S. Dummer, T. L. Anderson, and S. Goodman, “Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs,” Clinical Infectious Diseases, vol. 20, no. 4, pp. 1052–1054, 1995.
[20]  G. Gordon and N. A. Giddings, “Invasive otitis externa due to Aspergillus species: case report and review,” Clinical Infectious Diseases, vol. 19, no. 5, pp. 866–870, 1994.
[21]  E. Hanna, G. Hughes, I. Eliachar, J. Wanamaker, and W. Tomford, “Fungal osteomyelitis of the temporal bone: a review of reported cases,” Ear, Nose and Throat Journal, vol. 72, no. 8, pp. 532–541, 1993.
[22]  P. Reiss, R. Hadderingh, L. J. Schot, and S. A. Danner, “Invasive external otitis caused by Aspergillus fumigatus in two patients with AIDS,” AIDS, vol. 5, no. 5, pp. 605–606, 1991.
[23]  P. Phillips, G. Bryce, J. Shepherd, and D. Mintz, “Invasive external otitis caused by Aspergillus,” Reviews of Infectious Diseases, vol. 12, no. 2, pp. 277–281, 1990.
[24]  M. R. Menachof and R. K. Jackler, “Otogenic skull base osteomyelitis caused by invasive fungal infection,” Otolaryngology, vol. 102, no. 3, pp. 285–289, 1990.
[25]  D. W. Denning, R. M. Tucker, L. H. Hanson, and D. A. Stevens, “Treatment of invasive aspergillosis with itraconazole,” American Journal of Medicine, vol. 86, no. 6, pp. 791–800, 1989.
[26]  M. Cunningham, V. L. Yu, J. Turner, and H. Curtin, “Necrotizing otitis externa due to Aspergillus in an immunocompetent patient,” Archives of Otolaryngology, vol. 114, no. 5, pp. 554–556, 1988.
[27]  L. S. Bickley, R. F. Betts, and C. W. Parkins, “Atypical invasive external otitis from Aspergillus,” Archives of Otolaryngology, vol. 114, no. 9, pp. 1024–1028, 1988.
[28]  R. M. Petrak, J. C. Pottage Jr., and S. Levin, “Invasive external otitis caused by Aspergillus fumigatus in an immunocompromised patient,” Journal of Infectious Diseases, vol. 151, no. 1, p. 196, 1985.
[29]  M. T. Hedayati, A. C. Pasqualotto, P. A. Warn, P. Bowyer, and D. W. Denning, “Aspergillus flavus: human pathogen, allergen and mycotoxin producer,” Microbiology, vol. 153, no. 6, pp. 1677–1692, 2007.
[30]  V. Franco-Vidal, H. Blanchet, C. Bebear, H. Dutronc, and V. Darrouzet, “Necrotizing external otitis: a report of 46 cases,” Otology and Neurotology, vol. 28, no. 6, pp. 771–773, 2007.
[31]  T. J. Walsh, E. J. Anaissie, D. W. Denning et al., “Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America,” Clinical Infectious Diseases, vol. 46, no. 3, pp. 327–360, 2008.
[32]  G. R. Thompson IIII and J. S. Lewis, “Pharmacology and clinical use of voriconazole,” Expert Opinion on Drug Metabolism and Toxicology, vol. 6, no. 1, pp. 83–94, 2010.
[33]  Y. Hamzany, E. Soudry, M. Preis et al., “Fungal malignant external otitis,” Journal of Infection, vol. 62, no. 3, pp. 226–231, 2011.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133